Athena Countouriotis
2020
In 2020, Athena Countouriotis earned a total compensation of $15.3M as President and Chief Executive Officer at Turning Point Therapeutics, a 388% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $539,400 |
|---|---|
| Option Awards | $14,131,423 |
| Salary | $580,000 |
| Other | $11,400 |
| Total | $15,262,223 |
Countouriotis received $14.1M in option awards, accounting for 93% of the total pay in 2020.
Countouriotis also received $539.4K in non-equity incentive plan, $580K in salary and $11.4K in other compensation.
Rankings
In 2020, Athena Countouriotis' compensation ranked 389th out of 13,090 executives tracked by ExecPay. In other words, Countouriotis earned more than 97.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 389 out of 13,090 | 97th |
Division Manufacturing | 136 out of 5,624 | 98th |
Major group Chemicals And Allied Products | 46 out of 2,257 | 98th |
Industry group Drugs | 40 out of 1,957 | 98th |
Industry Pharmaceutical Preparations | 28 out of 1,462 | 98th |
Source: SEC filing on April 29, 2022.
Countouriotis' colleagues
We found four more compensation records of executives who worked with Athena Countouriotis at Turning Point Therapeutics in 2020.